NCCN Guidelines for Patients® | Prostate Cancer - page 86

86
NCCN Guidelines for Patients
®
: Prostate Cancer
Version 1.2014
NCCN Panel Members for Prostate Cancer
James L. Mohler, MD/Chair
Roswell Park Cancer Institute
Philip W. Kantoff, MD/Vice Chair
Dana-Farber/Brigham and Women’s
Cancer Center | Massachusetts
General Hospital Cancer Center
Andrew J. Armstrong, MD, ScM
Duke Cancer Institute
Robert R. Bahnson, MD
The Ohio State University
Comprehensive Cancer Center -
James Cancer Hospital and
Solove Research Institute
Michael Cohen, MD
Huntsman Cancer Institute
at the University of Utah
Anthony Victor D’Amico, MD, PhD
Dana-Farber/Brigham and Women’s
Cancer Center | Massachusetts
General Hospital Cancer Center
James A. Eastham, MD
Memorial Sloan-Kettering
Cancer Center
Charles A. Enke, MD
UNMC Eppley Cancer Center at
The Nebraska Medical Center
Thomas A. Farrington
Patient Advocate
Prostate Health Education Network
(PHEN)
Celestia S. Higano, MD
Fred Hutchinson Cancer Research
Center/ Seattle Cancer Care Alliance
Eric Mark Horwitz, MD
Fox Chase Cancer Center
Christopher J. Kane, MD
UC San Diego Moores Cancer Center
Mark H. Kawachi, MD
City of Hope Comprehensive
Cancer Center
Michael Kuettel, MD, MBA, PhD
Roswell Park Cancer Institute
Richard J. Lee, MD, PhD
Dana-Farber/Brigham and Women’s
Cancer Center | Massachusetts
General Hospital Cancer Center
Arnold W. Malcolm, MD
Vanderbilt-Ingram Cancer Center
David Miller, MD, MPH
University of Michigan
Comprehensive Cancer Center
Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center
Julio M. Pow-Sang, MD
Moffitt Cancer Center
Sylvia Richey, MD
St. Jude Children’s Research
Hospital/University of Tennessee
Cancer Institute
Mack Roach, III, MD
UCSF Helen Diller Family
Comprehensive Cancer Center
Eric Rohren, MD, PhD
The University of Texas
MD Anderson Cancer Center
Stan Rosenfeld
Patient Advocate University of
California San Francisco
Patient Services Committee Chair
1...,76,77,78,79,80,81,82,83,84,85 87,88,89,90,91,92
Powered by FlippingBook